US20210061799A1 - 11-ARYLCINNOLINO[2,3-f]PHENANTHRIDINIUM SALTS AND METHOD FOR PRODUCING THE SAME - Google Patents
11-ARYLCINNOLINO[2,3-f]PHENANTHRIDINIUM SALTS AND METHOD FOR PRODUCING THE SAME Download PDFInfo
- Publication number
- US20210061799A1 US20210061799A1 US16/664,370 US201916664370A US2021061799A1 US 20210061799 A1 US20210061799 A1 US 20210061799A1 US 201916664370 A US201916664370 A US 201916664370A US 2021061799 A1 US2021061799 A1 US 2021061799A1
- Authority
- US
- United States
- Prior art keywords
- arylcinnolino
- methoxy
- phenanthridinium
- group
- following formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 9
- 150000003839 salts Chemical class 0.000 title abstract description 27
- -1 salt compounds Chemical class 0.000 claims abstract description 100
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 36
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 claims description 24
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 24
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 21
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 claims description 18
- 229910052731 fluorine Inorganic materials 0.000 claims description 15
- 239000011737 fluorine Substances 0.000 claims description 15
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 15
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 15
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 14
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 claims description 12
- 125000003118 aryl group Chemical group 0.000 claims description 12
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 12
- 229910052805 deuterium Inorganic materials 0.000 claims description 12
- 229910052739 hydrogen Inorganic materials 0.000 claims description 12
- 239000001257 hydrogen Substances 0.000 claims description 12
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims description 12
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 11
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 11
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 10
- 125000000217 alkyl group Chemical group 0.000 claims description 6
- 150000001408 amides Chemical class 0.000 claims description 6
- 125000004744 butyloxycarbonyl group Chemical group 0.000 claims description 6
- TXKMVPPZCYKFAC-UHFFFAOYSA-N disulfur monoxide Inorganic materials O=S=S TXKMVPPZCYKFAC-UHFFFAOYSA-N 0.000 claims description 6
- 150000002148 esters Chemical group 0.000 claims description 6
- 125000000468 ketone group Chemical group 0.000 claims description 6
- 150000002825 nitriles Chemical class 0.000 claims description 6
- AUONHKJOIZSQGR-UHFFFAOYSA-N oxophosphane Chemical compound P=O AUONHKJOIZSQGR-UHFFFAOYSA-N 0.000 claims description 6
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 claims description 6
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims description 6
- XTQHKBHJIVJGKJ-UHFFFAOYSA-N sulfur monoxide Chemical compound S=O XTQHKBHJIVJGKJ-UHFFFAOYSA-N 0.000 claims description 6
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims description 3
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 claims description 3
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 claims description 3
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 claims description 3
- 125000006678 phenoxycarbonyl group Chemical group 0.000 claims description 3
- 229930194542 Keto Natural products 0.000 claims 2
- JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical compound O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 claims 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 125000001153 fluoro group Chemical group F* 0.000 claims 1
- 239000000463 material Substances 0.000 abstract description 7
- 150000001336 alkenes Chemical class 0.000 abstract description 6
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 abstract description 4
- 230000015572 biosynthetic process Effects 0.000 abstract description 4
- 238000006243 chemical reaction Methods 0.000 abstract description 4
- 238000003786 synthesis reaction Methods 0.000 abstract description 4
- 238000010499 C–H functionalization reaction Methods 0.000 abstract description 2
- 238000005966 aza-Michael addition reaction Methods 0.000 abstract description 2
- 230000008878 coupling Effects 0.000 abstract description 2
- 238000010168 coupling process Methods 0.000 abstract description 2
- 238000005859 coupling reaction Methods 0.000 abstract description 2
- 230000007246 mechanism Effects 0.000 abstract description 2
- 238000006772 olefination reaction Methods 0.000 abstract description 2
- 230000001590 oxidative effect Effects 0.000 abstract description 2
- 229910052763 palladium Inorganic materials 0.000 abstract description 2
- 125000003367 polycyclic group Chemical group 0.000 abstract description 2
- 238000006894 reductive elimination reaction Methods 0.000 abstract description 2
- 238000010507 β-hydride elimination reaction Methods 0.000 abstract description 2
- 238000006555 catalytic reaction Methods 0.000 abstract 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 abstract 1
- 0 *C.*C1=C2C=CC=C(C3=CC=CC=C3)C2=NN2=C1C1=C(C=CC=C1)C1=C2C=CC=C1.FB(F)F.[1*]C.[2*]C.[2*]C.[F-] Chemical compound *C.*C1=C2C=CC=C(C3=CC=CC=C3)C2=NN2=C1C1=C(C=CC=C1)C1=C2C=CC=C1.FB(F)F.[1*]C.[2*]C.[2*]C.[F-] 0.000 description 31
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 16
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 8
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 3
- DHOKCZIVZPGGLM-OCEACIFDSA-N C1=CC=C(C2=CC=CC=C2/N=N/C2=C(C3=CC=CC=C3)C=CC=C2)C=C1 Chemical compound C1=CC=C(C2=CC=CC=C2/N=N/C2=C(C3=CC=CC=C3)C=CC=C2)C=C1 DHOKCZIVZPGGLM-OCEACIFDSA-N 0.000 description 3
- SBVLGNNEOLOQKI-BTKVJIOYSA-N C1=CC=C(C2=CC=CC=C2/N=N/C2=C(C3=CC=CC=C3)C=CC=C2)C=C1.NC1=C(C2=CC=CC=C2)C=CC=C1 Chemical compound C1=CC=C(C2=CC=CC=C2/N=N/C2=C(C3=CC=CC=C3)C=CC=C2)C=C1.NC1=C(C2=CC=CC=C2)C=CC=C1 SBVLGNNEOLOQKI-BTKVJIOYSA-N 0.000 description 3
- CQEYYJKEWSMYFG-UHFFFAOYSA-N butyl acrylate Chemical compound CCCCOC(=O)C=C CQEYYJKEWSMYFG-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 235000019439 ethyl acetate Nutrition 0.000 description 3
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- JPIIBJZRXUFNPS-UHFFFAOYSA-M CCCCOC(=O)C1=C2C=CC=C(C3=C(C)C=CC=C3)C2=NN2=C1C1=C(C(Cl)=CC=C1)C1=C2C=CC=C1.FB(F)F.[F-] Chemical compound CCCCOC(=O)C1=C2C=CC=C(C3=C(C)C=CC=C3)C2=NN2=C1C1=C(C(Cl)=CC=C1)C1=C2C=CC=C1.FB(F)F.[F-] JPIIBJZRXUFNPS-UHFFFAOYSA-M 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 239000005909 Kieselgur Substances 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- YLEIFZAVNWDOBM-ZTNXSLBXSA-N ac1l9hc7 Chemical compound C([C@H]12)C[C@@H](C([C@@H](O)CC3)(C)C)[C@@]43C[C@@]14CC[C@@]1(C)[C@@]2(C)C[C@@H]2O[C@]3(O)[C@H](O)C(C)(C)O[C@@H]3[C@@H](C)[C@H]12 YLEIFZAVNWDOBM-ZTNXSLBXSA-N 0.000 description 2
- OPQARKPSCNTWTJ-UHFFFAOYSA-L copper(ii) acetate Chemical compound [Cu+2].CC([O-])=O.CC([O-])=O OPQARKPSCNTWTJ-UHFFFAOYSA-L 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000011368 organic material Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 238000006862 quantum yield reaction Methods 0.000 description 2
- 238000010898 silica gel chromatography Methods 0.000 description 2
- 229910001494 silver tetrafluoroborate Inorganic materials 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 229910052723 transition metal Inorganic materials 0.000 description 2
- 150000003624 transition metals Chemical class 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- OCJBOOLMMGQPQU-UHFFFAOYSA-N 1,4-dichlorobenzene Chemical compound ClC1=CC=C(Cl)C=C1 OCJBOOLMMGQPQU-UHFFFAOYSA-N 0.000 description 1
- 238000004607 11B NMR spectroscopy Methods 0.000 description 1
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- 238000004293 19F NMR spectroscopy Methods 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 1
- MKHWOYODMHBBRI-NZZXTCJYSA-N C1=CC=C(C2=CC=CC=C2/N=N/C2=C(C3=CC=CC=C3)C=CC=C2)C=C1.C=CC(=O)OCCCC.CCCCOC(=O)C1(O)C2=C(NN3=C1C1=C(C=CC=C1)C1=C3C=CC=C1)C(C1=CC=CC=C1)=CC=C2 Chemical compound C1=CC=C(C2=CC=CC=C2/N=N/C2=C(C3=CC=CC=C3)C=CC=C2)C=C1.C=CC(=O)OCCCC.CCCCOC(=O)C1(O)C2=C(NN3=C1C1=C(C=CC=C1)C1=C3C=CC=C1)C(C1=CC=CC=C1)=CC=C2 MKHWOYODMHBBRI-NZZXTCJYSA-N 0.000 description 1
- WLWNVOCWGHXISK-OJIHKMEMSA-M C1=CC=C(C2=CC=CC=C2/N=N/C2=C(C3=CC=CC=C3)C=CC=C2)C=C1.C=CC(=O)OCCCC.CCCCOC(=O)C1=C2C=CC=C(C3=CC=CC=C3)C2=NN2=C1C1=C(C=CC=C1)C1=C2C=CC=C1.FB(F)F.[F-] Chemical compound C1=CC=C(C2=CC=CC=C2/N=N/C2=C(C3=CC=CC=C3)C=CC=C2)C=C1.C=CC(=O)OCCCC.CCCCOC(=O)C1=C2C=CC=C(C3=CC=CC=C3)C2=NN2=C1C1=C(C=CC=C1)C1=C2C=CC=C1.FB(F)F.[F-] WLWNVOCWGHXISK-OJIHKMEMSA-M 0.000 description 1
- 229910021592 Copper(II) chloride Inorganic materials 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 229940117389 dichlorobenzene Drugs 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000003818 flash chromatography Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000000155 isotopic effect Effects 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000005693 optoelectronics Effects 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- IUGYQRQAERSCNH-UHFFFAOYSA-N pivalic acid Chemical compound CC(C)(C)C(O)=O IUGYQRQAERSCNH-UHFFFAOYSA-N 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000027756 respiratory electron transport chain Effects 0.000 description 1
- 238000010129 solution processing Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- GKTQKQTXHNUFSP-UHFFFAOYSA-N thieno[3,4-c]pyrrole-4,6-dione Chemical compound S1C=C2C(=O)NC(=O)C2=C1 GKTQKQTXHNUFSP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
Definitions
- the invention relates to 11-arylcinnolino[2,3-f]phenanthridinium salt compounds and method for producing the same.
- Cinnolinium salts are receiving increasing attention due to their applications in organic optoelectronic materials, and specifically high molecular weight cinnolinium salts with good solubility in organic solvents have high potential. Nevertheless, traditional methods for the synthesis of cinnolinium salts are inefficient and costly, so there is room for improvement.
- the main object of the invention is to provide a 11-arylcinnolino[2,3-f]phenanthridinium salt compounds in higher yield and lower manufacturing cost.
- Another object of the invention is to provide a method for producing the 11-arylcinnolino[2,3-f]phenanthridinium salt compounds in higher yield and lower manufacturing cost.
- the 11-arylcinnolino[2,3-f]phenanthridinium salt compounds of the invention have the structure of the following formula (1):
- R 1 is selected from hydrogen (H), deuterium (D), methyl (Me), isopropyl ( i Pr), phenyl (Ph), methoxy (OMe), oxytrifluoromethyl (OCF 3 ), trifluoromethyl (CF 3 ), fluorine (F), dimethylamino (NMe 2 ), and cyano (CN);
- R 2 is selected from hydrogen (H), deuterium (D), methyl (Me), isopropyl ( i Pr), phenyl (Ph), methoxy (OMe), oxytrifluoromethyl (OCF 3 ), trifluoromethyl (CF 3 ), fluorine (F), dimethylamino (NMe 2 ), and cyano (CN);
- R is selected from the group consisting of an ester (CO 7 R′), an amide (CONR′ 2 ), a ketone group (COR′), aryl (Ar), a nitrile (CN), a nitro group (NO 2 ), trifluoromethyl (CF 3 ), a phosphonate(P( ⁇ O)OR′ 2 ), a phosphine oxide (P( ⁇ O)R′ 2 ), a sulfonyl group (SOR′), and a sulfur oxide (SO 2 R′), and R′ is selected from a group consisting of alkyl and aryl.
- the 11-arylcinnolino[2,3-f]phenanthridinium salt compounds have the structure of the following formula (A):
- R is selected from the group consisting of methoxycarbonvl (CO 2 Me). butoxycarbonyl (CO 2 Bu), ethoxycarbonyl (CO 2 Et), (benzyloxy)carbonyl (CO 2 Bn). (cyclohexyloxy)carbonyl (CO 2 cyhex), ((tetrahydrofuran-2-yl)methoxy)carbonyl (CO 2 furfuryl), phenoxycarbonyl (CO 2 Ph), and dimethylcarbamoyl (CONMe 2 ).
- the 11-arylcinnolino[2,3-f]phenanthridinium salt compounds have the structure of the following formula (A):
- R is selected from the group consisting of acetyl (COMe) and phenyl (Ph).
- the 11-arylcinnolino[2,3-f]phenanthridinium salt compounds of claim 1 have the structure of the following formula (B):
- R is selected from the group consisting of ((tetrahydrofuran-2-yl) methoxy)carbonyl (CO 2 furfuryl) and dimethylcarbamoyl (CONMe 2 ).
- the 11-arylcinnolino[2,3-f]phenanthridinium salt compounds include 15-(((tetrahydrofuran-2-yl)methoxy)carbonyl)-7,14-dimethyl-11-phenylcinnolino[2,3-f]phenanthridin-9-ium tetrafluoroborate, and have the structure of the following formula (C):
- R includes ((tetrahydrofuran-2-yl)methoxy)carbonyl (CO 2 furfuryl).
- the 11-arylcinnolino[2,3-f]phenanthridinium salt compounds include 15-(butoxycarbonyl)-3-methyl-11-(m-tolyl)cinnolino[2,3-f] phenanthridin-9-ium tetrafluoroborate, and have the structure of the following formula (D):
- R includes butoxycarbonyl (CO 2 Bu), and R 2 includes methyl (Me).
- the 11-arylcinnolino [2,3-f]phenanthridinium salt compounds include 3-fluoro-11-(3-fluorophenyl)-15-(((tetrahydrofuran-2-yl)methoxy) carbonyl)cinnolino[2,3-f]phenanthridin-9-ium tetrafluoroborate, and have the structure of the following formula (E):
- R includes ((tetrahydrofuran-2-yl)methoxy)carbonyl (CO 2 furfuryl), and R 2 includes fluorine.
- the 11-arylcinnolino[2,3-f]phenanthridinium salt compounds of claim 1 include 15-(butoxycarbonyl)-4-chloro-11-(2-chlorophenyl) cinnolino[2,3-f]phenanthridin-9-ium tetrafluoroborate, and have the structure of the following formula (F):
- the 11-arylcinnolino[2,3-f]phenanthridinium salt compounds include 14-(((tetrahydrofuran-2-yl)methoxy)carbonyl)-10-(thiophen-2-yl)thieno[3′.2′:3.4]quinolino[1,2-b]cinnolin-8-ium tetrafluoroborate, and have the structure of the following formula (G):
- R′ is selected from hydrogen (H), deuterium (D), methyl (Me), isopropyl ( 1 Pr), phenyl (Ph), methoxy (OMe), oxytrifluoromethyl (OCF 3 ), trifluoromethyl (CF 3 ), fluorine (F), dimethylamino (NMe 2 ), and cyano (CN);
- R 2 is selected from hydrogen (H), deuterium (D), methyl (Me), isopropyl ( 1 Pr), phenyl (Ph), methoxy (OMe), oxytrifluoromethyl (OCF 3 ), trifluoromethyl (CF 3 ), fluorine (F), dimethylamino (NMe 2 ), and cyano (CN);
- R is selected from the group consisting of an ester (CO 2 R′), an amide (CONR′ 2 ), a ketone group (COR′), aryl (Ar), a nitrile (CN), a nitro group (NO 2 ), trifluoromethyl(CF 3 ), a phosphonate (P( ⁇ O)OR′ 2 ), a phosphine oxide (P( ⁇ O)R′ 2 ), a sulfonyl group (SOR′), and a sulfur oxide (SO 2 R′), and R′ is selected from a group consisting of alkyl and aryl.
- 2-azobiaryls are produced by the following equation.
- FIG. 1 Light absorption testing results.
- FIG. 2 Fluorescence testing results.
- the 11-arylcinnolino[2,3-f]phenanthridinium salt compounds of the invention have the structure of the following formula (1):
- R 1 is selected from hydrogen (H), deuterium (D), methyl (Me), isopropyl ( 1 Pr), phenyl (Ph), methoxy (OMe), oxytrifluoromethyl (OCF 3 ), trifluoromethyl (CF 3 ), fluorine (F), dimethylamino (NMe 2 ), and cyano (CN);
- R 2 is selected from hydrogen (H), deuterium (D), methyl (Me), isopropyl ( i Pr), phenyl (Ph), methoxy (OMe), oxytrifluoromethyl (OCF 3 ), trifluoromethyl (CF 3 ), fluorine (F), dimethylamino (NMe 2 ), and cyano (CN);
- R is selected from the group consisting of an ester (CO 2 R′), an amide (CONR′2), a ketone group (COR′), aryl (Ar), a nitrile (CN), a nitro group (NO 2 ), trifluoromethyl (CF 3 ), a phosphonate (P( ⁇ O)OR′ 2 ), a phosphine oxide (P( ⁇ O)R′ 2 ), a sulfonyl group (SOR′), and a sulfur oxide (SO 2 R′), and R′ is selected from a group consisting of alkyl and aryl.
- the 11-arylcinnolino[2,3-f]phenanthridinium salt compounds are produced by the following equation,
- R 1 is selected from hydrogen (H), deuterium (D), methyl (Me), isopropyl ( i Pr), phenyl (Ph), methoxy (OMe), oxytrifluoromethyl (OCF 3 ), trifluoromethyl (CF 3 ), fluorine (F), dimethylamino (NMe 2 ), and cyano (CN);
- R 2 is selected from hydrogen (H), deuterium (D), methyl (Me), isopropyl ( i Pr), phenyl (Ph), methoxy (OMe), oxytrifluoromethyl (OCF 3 ), trifluoromethyl (CF 3 ), fluorine (F), dimethylamino (NMe 2 ), and cyano (CN);
- R is selected from the group consisting of an ester (CO 2 R′), an amide (CONR′ 2 ), a ketone group (COR′), aryl (Ar), a nitrile (CN), a nitro group (NO 2 ), trifluoromethyl (CF 3 ), a phosphonate (P( ⁇ O)OR′ 2 ), a phosphine oxide (P( ⁇ O)R′ 2 ), a sulfonyl group (SOR′), and a sulfur oxide (SO 2 R′), and R′ is selected from a group consisting of alkyl and aryl.
- the product mixture of the reaction was cooled to room temperature, and diluted with CH 2 Cl 2 (10 mL); then, the solution was subject to vacuum concentration, and the residue was purified by silica gel column chromatography (Pet ether; EtOAc/MeOH ( ⁇ 5%)) to serve as an intermediate complex. Then, the intermediate complex was treated with AgBF 4 (2.5 eqiuv) in dichloromethane as a solvent, stirred at room temperature for 2-5 minutes, filtered by diatomaceous earth, and subjected to vacuum concentration to obtain a 15-(butoxycarbonyl)-11-phenylcinnolino[2,3-f] phenanthridin-9-ium tetrafluoroborate salt (4ab).
- 2-azobiaryls are produced by the following equation,
- the product mixture of the reaction was cooled to room temperature, and diluted with CH 2 Cl 2 (10 mL); then, the solution was subject to vacuum concentration, and the residue was purified by silica gel column chromatography (Pet ether; EtOAc/MeOH ( ⁇ 5%)) to serve as an intermediate complex. Then, the intermediate complex was treated with AgBF 4 (2.5 eqiuv) in dichloromethane as a solvent, stirred at room temperature for 2-5 minutes, filtered by diatomaceous earth, and subjected to vacuum concentration to obtain a 15-(butoxycarbonyl)-15-hydroxy-11-phenyl-15H-cinnolino[2,3-f] phenanthridin-9-ium-10 salt (5ab) with a required yield. Wherein the salt (5ab) was preferably stored in methanol at 5 degrees centigrade.
- 2-azo-biaryls and butyl acrylate can react to form 11-arylcinnolino[2,3-f]phenanthridinium salts in the presence of Pd(OAc) 2 as a catalyst.
- Pd(OAc) 2 as a catalyst.
- a highly regioselective synthesis of 11-arylcinnolino[2,3-f]phenanthridin-9-ium salts from 2-azobiaryls and alkenes is catalyzed by palladium, through double oxidative C—H coupling of alkenes, giving polycyclic cinnolinium salts in moderate yields.
- the reaction mechanism involves ortho C—H olefination of 2-azobiaryls by alkenes, intramolecular aza-Michael addition. ⁇ -hydride elimination, electrophilic palladation followed by intramolecular C—H activation and reductive elimination.
- the resulted 11-arylcinnolino[2,3-f]phenanthridinium salt compounds have a high molecular weight. and a good solubility greater than 20 mg/ml in various organic solvents, including toluene, dichloromethane, chloroform, dichlorobenzene, 1,4-dioxane and tetrahydrofuran.
- the salts have high potential for the solution processing of an orange-red OLED material and bioimaging application.
- Traditional fluorescent orange-red materials all depend on transition metal-containing luminous bodies, and the transition metal-containing luminous bodies usually have lower internal quantum yield and a broader spectrum.
- a metal-free luminous body has higher solubility and quantum yield, recent development gradually focuses on the design and synthesis of a metal-free organic material.
- the organic material usually having a functional group capable of pushing and pulling electrons to lead to electron transfer, appears as a narrow bandwidth orange-red organic light-emitting diode. Therefore, the 11-arylcinnolino[2,3-f]phenanthridin-9-ium salts can have high potential to serve as a solution-processed orange-red OLED material.
- 11-arylcinnolino[2,3-f]phenanthridinium salt compounds have the structure of the following formula (A):
- R is selected from the group consisting of methoxycarbonyl (CO 2 Me), butoxycarbonyl (CO 2 Bu), ethoxycarbonyl (CO 2 Et), (benzyloxy)carbonyl (CO 2 Bn), (cyclohexyloxy)carbonyl (CO 2 cyhex), ((tetrahydrofuran-2-yl)methoxy)carbonyl (CO 2 furfuryl), phenoxycarbonyl (CO 7 Ph), and dimethylcarbamoyl (CONMe 2 ).
- the 11-arylcinnolino[2,3-f]phenanthridin-9-ium salts are included in Table 1 below.
- the 11-arylcinnolino[2,3-f]phenanthridinium salt compounds have the structure of the following formula (A):
- R is selected from the group consisting of acetyl (COMe) and phenyl (Ph).
- the 11-arylcinnolino[2,3-f]phenanthridinium salt compounds of claim 1 have the structure of the following formula (B):
- R is selected from the group consisting, of ((tetrahydrofuran-2-yl)methoxy)carbonyl (CO 2 furfuryl) and dimethylcarbamoyl (CONMe 2 ).
- the 11-arylcinnolino[2,3-f] phenanthridinium salt compounds include 15-(dimethylcarbamoyl)-7,14-dimethyl-11-phenylcinnolino[2,3-f]phenanthridin-9-ium tetrafluoroborate, and have the structure of the following formula (C):
- the 11-arylcinnolino[2,3-f] phenanthridinium salt compounds include 15-(butoxycarbonyl)-3-methyl-11-(m-tolyl)cinnolino[2,3-f]phenanthridin-9-ium tetrafluoroborate, and have the structure of the following formula (D):
- R includes butoxycarbonyl (CO 2 Bu), and R 2 includes methyl (Me).
- the 11-arylcinnolino[2,3-]phenanthridinium salt compounds include 3-fluoro-11-(3-fluorophenyl)-15-(((tetrahydrofuran-2-yl)methoxy)carbonyl)cinnolino[2,3-f] phenanthridin-9-ium tetrafluoroborate, and have the structure of the following formula (E):
- R includes ((tetrahydrofuran-2-yl)methoxy)carbonyl (CO 2 furfuryl), and R 2 includes fluorine.
- the 11-arylcinnolino[2,3-f]phenanthridinium salt compounds of claim 1 include 15-(butoxycarbonyl)-4-chloro-11-(2-chlorophenyl)cinnolino[2,3-f]phenanthridin-9-ium tetrafluoroborate, and have the structure of the following formula (F):
- the 11-arylcinnolino[2,3-f]phenanthridinium salt compounds include 14-(((tetrahydrofuran-2-yl)methoxy)carbonyl)-10-(thiophen-2-yl)thieno[3′,2′:3,4]quinolino[1,2-b]cinnolin-8-ium tetrafluoroborate, and have the structure of the following formula (G):
- the absorption test and the fluorescence test (1.0 ⁇ 10 ⁇ 5 M, excitation wavelength: 360 nm, in dichloromethane) were performed on the compounds 2a, 4ab, 4ad, 4ah, 4aj, and 4bf, and the results were shown in FIGS. 1 and 2 respectively.
- the maximum absorption peak for the compound 2a appears at 275-400 nm
- the maximum absorption peaks for the compounds 4ab, 4ad, 4ah, and 4aj appear at 340 nm
- the maximum absorption peak for the compound 4bf appears at 380 nm.
- the compounds 2a, 4ab, 4ad, 4ah, 4aj, and 4bf were excited at the wavelengths of respective maximum absorption peaks, the compound 2a was not found to emit fluorescence, while the compounds 4ab, 4ad, 4ah, 4aj, and 4bf can emit orange-red fluorescence at 500-750 nm. These salts exhibit large Stokes shift orange-red fluorescence, which show possible application in IDLED and bioimaging.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
- The invention relates to 11-arylcinnolino[2,3-f]phenanthridinium salt compounds and method for producing the same.
- Cinnolinium salts are receiving increasing attention due to their applications in organic optoelectronic materials, and specifically high molecular weight cinnolinium salts with good solubility in organic solvents have high potential. Nevertheless, traditional methods for the synthesis of cinnolinium salts are inefficient and costly, so there is room for improvement.
- The main object of the invention is to provide a 11-arylcinnolino[2,3-f]phenanthridinium salt compounds in higher yield and lower manufacturing cost.
- Another object of the invention is to provide a method for producing the 11-arylcinnolino[2,3-f]phenanthridinium salt compounds in higher yield and lower manufacturing cost.
- The 11-arylcinnolino[2,3-f]phenanthridinium salt compounds of the invention have the structure of the following formula (1):
- wherein, R1 is selected from hydrogen (H), deuterium (D), methyl (Me), isopropyl (iPr), phenyl (Ph), methoxy (OMe), oxytrifluoromethyl (OCF3), trifluoromethyl (CF3), fluorine (F), dimethylamino (NMe2), and cyano (CN);
- R2 is selected from hydrogen (H), deuterium (D), methyl (Me), isopropyl (iPr), phenyl (Ph), methoxy (OMe), oxytrifluoromethyl (OCF3), trifluoromethyl (CF3), fluorine (F), dimethylamino (NMe2), and cyano (CN);
- R is selected from the group consisting of an ester (CO7R′), an amide (CONR′2), a ketone group (COR′), aryl (Ar), a nitrile (CN), a nitro group (NO2), trifluoromethyl (CF3), a phosphonate(P(═O)OR′2), a phosphine oxide (P(═O)R′2), a sulfonyl group (SOR′), and a sulfur oxide (SO2R′), and R′ is selected from a group consisting of alkyl and aryl.
- In an embodiment of the invention, the 11-arylcinnolino[2,3-f]phenanthridinium salt compounds have the structure of the following formula (A):
- wherein, R is selected from the group consisting of methoxycarbonvl (CO2Me). butoxycarbonyl (CO2Bu), ethoxycarbonyl (CO2Et), (benzyloxy)carbonyl (CO2Bn). (cyclohexyloxy)carbonyl (CO2cyhex), ((tetrahydrofuran-2-yl)methoxy)carbonyl (CO2furfuryl), phenoxycarbonyl (CO2Ph), and dimethylcarbamoyl (CONMe2).
- In an embodiment of the invention, the 11-arylcinnolino[2,3-f]phenanthridinium salt compounds have the structure of the following formula (A):
- wherein, R is selected from the group consisting of acetyl (COMe) and phenyl (Ph).
- In an embodiment of the invention, the 11-arylcinnolino[2,3-f]phenanthridinium salt compounds of claim 1 have the structure of the following formula (B):
- wherein, R is selected from the group consisting of ((tetrahydrofuran-2-yl) methoxy)carbonyl (CO2furfuryl) and dimethylcarbamoyl (CONMe2).
- In an embodiment of the invention, the 11-arylcinnolino[2,3-f]phenanthridinium salt compounds include 15-(((tetrahydrofuran-2-yl)methoxy)carbonyl)-7,14-dimethyl-11-phenylcinnolino[2,3-f]phenanthridin-9-ium tetrafluoroborate, and have the structure of the following formula (C):
- wherein, R includes ((tetrahydrofuran-2-yl)methoxy)carbonyl (CO2furfuryl).
- In an embodiment of the invention, the 11-arylcinnolino[2,3-f]phenanthridinium salt compounds include 15-(butoxycarbonyl)-3-methyl-11-(m-tolyl)cinnolino[2,3-f] phenanthridin-9-ium tetrafluoroborate, and have the structure of the following formula (D):
- wherein, R includes butoxycarbonyl (CO2Bu), and R2 includes methyl (Me).
- In an embodiment of the invention, the 11-arylcinnolino [2,3-f]phenanthridinium salt compounds include 3-fluoro-11-(3-fluorophenyl)-15-(((tetrahydrofuran-2-yl)methoxy) carbonyl)cinnolino[2,3-f]phenanthridin-9-ium tetrafluoroborate, and have the structure of the following formula (E):
- wherein, R includes ((tetrahydrofuran-2-yl)methoxy)carbonyl (CO2furfuryl), and R2 includes fluorine.
- In an embodiment of the invention, the 11-arylcinnolino[2,3-f]phenanthridinium salt compounds of claim 1 include 15-(butoxycarbonyl)-4-chloro-11-(2-chlorophenyl) cinnolino[2,3-f]phenanthridin-9-ium tetrafluoroborate, and have the structure of the following formula (F):
- In an embodiment of the invention, the 11-arylcinnolino[2,3-f]phenanthridinium salt compounds include 14-(((tetrahydrofuran-2-yl)methoxy)carbonyl)-10-(thiophen-2-yl)thieno[3′.2′:3.4]quinolino[1,2-b]cinnolin-8-ium tetrafluoroborate, and have the structure of the following formula (G):
- Provided is a method for producing the 11-arylcinnolino[2,3-f]phenanthridinium salt compounds of the invention by the following equation.
- wherein, the 11-arylcinnolino[2,3-f]phenanthridinium salt compounds have the structure of the following formula (1):
- R′ is selected from hydrogen (H), deuterium (D), methyl (Me), isopropyl (1Pr), phenyl (Ph), methoxy (OMe), oxytrifluoromethyl (OCF3), trifluoromethyl (CF3), fluorine (F), dimethylamino (NMe2), and cyano (CN);
- R2 is selected from hydrogen (H), deuterium (D), methyl (Me), isopropyl (1Pr), phenyl (Ph), methoxy (OMe), oxytrifluoromethyl (OCF3), trifluoromethyl (CF3), fluorine (F), dimethylamino (NMe2), and cyano (CN);
- R is selected from the group consisting of an ester (CO2R′), an amide (CONR′2), a ketone group (COR′), aryl (Ar), a nitrile (CN), a nitro group (NO2), trifluoromethyl(CF3), a phosphonate (P(═O)OR′2), a phosphine oxide (P(═O)R′2), a sulfonyl group (SOR′), and a sulfur oxide (SO2R′), and R′ is selected from a group consisting of alkyl and aryl.
- In an embodiment, 2-azobiaryls are produced by the following equation.
- wherein the 2-azobiaryls have the structure of formula (2):
-
FIG. 1 : Light absorption testing results. -
FIG. 2 : Fluorescence testing results. - The 11-arylcinnolino[2,3-f]phenanthridinium salt compounds of the invention have the structure of the following formula (1):
- wherein, R1 is selected from hydrogen (H), deuterium (D), methyl (Me), isopropyl (1Pr), phenyl (Ph), methoxy (OMe), oxytrifluoromethyl (OCF3), trifluoromethyl (CF3), fluorine (F), dimethylamino (NMe2), and cyano (CN);
- R2 is selected from hydrogen (H), deuterium (D), methyl (Me), isopropyl (iPr), phenyl (Ph), methoxy (OMe), oxytrifluoromethyl (OCF3), trifluoromethyl (CF3), fluorine (F), dimethylamino (NMe2), and cyano (CN);
- R is selected from the group consisting of an ester (CO2R′), an amide (CONR′2), a ketone group (COR′), aryl (Ar), a nitrile (CN), a nitro group (NO2), trifluoromethyl (CF3), a phosphonate (P(⊚O)OR′2), a phosphine oxide (P(═O)R′2), a sulfonyl group (SOR′), and a sulfur oxide (SO2R′), and R′ is selected from a group consisting of alkyl and aryl.
- In an embodiment, the 11-arylcinnolino[2,3-f]phenanthridinium salt compounds are produced by the following equation,
- wherein, the 11-arylcinnolino[2,3-f]phenanthridinium salt compounds have the structure of the following formula (1):
- R1 is selected from hydrogen (H), deuterium (D), methyl (Me), isopropyl (iPr), phenyl (Ph), methoxy (OMe), oxytrifluoromethyl (OCF3), trifluoromethyl (CF3), fluorine (F), dimethylamino (NMe2), and cyano (CN);
- R2 is selected from hydrogen (H), deuterium (D), methyl (Me), isopropyl (iPr), phenyl (Ph), methoxy (OMe), oxytrifluoromethyl (OCF3), trifluoromethyl (CF3), fluorine (F), dimethylamino (NMe2), and cyano (CN);
- R is selected from the group consisting of an ester (CO2R′), an amide (CONR′2), a ketone group (COR′), aryl (Ar), a nitrile (CN), a nitro group (NO2), trifluoromethyl (CF3), a phosphonate (P(═O)OR′2), a phosphine oxide (P(═O)R′2), a sulfonyl group (SOR′), and a sulfur oxide (SO2R′), and R′ is selected from a group consisting of alkyl and aryl.
- More specifically, in an embodiment, according to the following equation,
- Pd(OAc)2 (0.01 mmol, 2.2 mg), Cu(OAc)2 (0.3 mmol, 54.3 mg), and CuCl2 (0.3 mmol, 40.4 mg) were added to a sealed test tube containing 2-azo-biaryls (2a, 0.1 mmol). Then, triflouroethanol (TFE, 2.0 mL) and butyl acrylate (3b, 0.2 mmol) were syringed to the mixture in sequence in the atmosphere. The mixture was heated to 100-120 degrees centigrade for 12-16 hours. The product mixture of the reaction was cooled to room temperature, and diluted with CH2Cl2 (10 mL); then, the solution was subject to vacuum concentration, and the residue was purified by silica gel column chromatography (Pet ether; EtOAc/MeOH (˜5%)) to serve as an intermediate complex. Then, the intermediate complex was treated with AgBF4 (2.5 eqiuv) in dichloromethane as a solvent, stirred at room temperature for 2-5 minutes, filtered by diatomaceous earth, and subjected to vacuum concentration to obtain a 15-(butoxycarbonyl)-11-phenylcinnolino[2,3-f] phenanthridin-9-ium tetrafluoroborate salt (4ab).
- Wherein the property measurement results of the salt (4ab) are shown as follows: Red solid; m.p. 204-209° C.; 1H NMR (700 MHz, CDCl3): δ 8.87 (d, J=8.4 Hz, 1H), 8.78 (d, J=8.4 Hz, 1H), 8.75 (d, J=7.7 Hz, 1H), 8.60 (d, J=8.4 Hz, 1H), 8.35-8.29 (m, 3H), 8.12 (t, J=7.7 Hz, 1H), 8.00 (t, J=7.7 Hz, 1H), 7.99-7.85 (m, 4H), 7.67-7.64 (m, 3H), 4.67 (t, J=11.2 Hz, 2H), 1.78-1.75 (m, 2H), 1.36-1.32 (m, 2H), 0.91 (t, J=7.7 Hz, 3H); 13C NMR (175 MHz, CDCl3): δ 164.7, 145.8, 142.4, 138.8, 137.8, 136.7, 135.6, 135.3, 134.9, 134.7, 132.8, 132.0, 131.3, 130.1, 129.8, 129.6, 128.8, 128.4, 126.7, 126.0, 124.0 123.8, 123.2, 121.9, 121.5, 68.7, 29.9, 18.9, 13.5; 11B NMR (191 MHz, CDCl3): δ −2.89; 19F NMR (563 MHz, CDCl3): δ −153.52, −153.57 and secondary isotopic shift (10B, 11B) of 0.05 ppm; HRMS (ESI+) calcd for C31H25N2O2 + 457.1911, found 457.1910; IR (KBr): 3085, 1675, 1581, 1056 (vB—F), 775 and 502 cm−1.
- In an embodiment, 2-azobiaryls are produced by the following equation,
- wherein the 2-azobiaryls have the structure of formula (2):
- More specifically, the substituted 2-amino-biaryls (1a, 2.00 mmol) were dissolved in toluene (15 mL) in a round-bottom flask, and then meta-chloroperoxybenzoic acid (516 mg, 3.00 mmol) was added in portions under nitrogen at 0 degrees centigrade. The reaction mixture was stirred at room temperature for 12-18 hours. Then, the crude product was purified by flash column chromatography (2% EtOAc in petroleum ether) to obtain the desirable product (2a) as orange solid in yield of 70%.
- In a different embodiment, according to the following equation,
- Pd(OAc)2 (0.01 mmol, 2.2 mg), Cu(OAc)2 (0.3 mmol, 54.3 mg), and PivOH (0.3 mmol, 40.4 mg) were added to a sealed test tube containing 2-azo-biaryls (2a, 0.1 mmol). Then, triflouroethanol (TFE, 2.0 mL) and butyl acrylate (3b, 0.2 mmol) were syringed to the mixture in sequence in the atmosphere. The mixture was heated to 100-120 degrees centigrade for 12-16 hours. The product mixture of the reaction was cooled to room temperature, and diluted with CH2Cl2 (10 mL); then, the solution was subject to vacuum concentration, and the residue was purified by silica gel column chromatography (Pet ether; EtOAc/MeOH (˜5%)) to serve as an intermediate complex. Then, the intermediate complex was treated with AgBF4 (2.5 eqiuv) in dichloromethane as a solvent, stirred at room temperature for 2-5 minutes, filtered by diatomaceous earth, and subjected to vacuum concentration to obtain a 15-(butoxycarbonyl)-15-hydroxy-11-phenyl-15H-cinnolino[2,3-f] phenanthridin-9-ium-10 salt (5ab) with a required yield. Wherein the salt (5ab) was preferably stored in methanol at 5 degrees centigrade.
- In other words, in a way similar to said equations, 2-azo-biaryls and butyl acrylate can react to form 11-arylcinnolino[2,3-f]phenanthridinium salts in the presence of Pd(OAc)2 as a catalyst. Furthermore, a highly regioselective synthesis of 11-arylcinnolino[2,3-f]phenanthridin-9-ium salts from 2-azobiaryls and alkenes is catalyzed by palladium, through double oxidative C—H coupling of alkenes, giving polycyclic cinnolinium salts in moderate yields. The reaction mechanism involves ortho C—H olefination of 2-azobiaryls by alkenes, intramolecular aza-Michael addition. β-hydride elimination, electrophilic palladation followed by intramolecular C—H activation and reductive elimination. On the other hand, the resulted 11-arylcinnolino[2,3-f]phenanthridinium salt compounds have a high molecular weight. and a good solubility greater than 20 mg/ml in various organic solvents, including toluene, dichloromethane, chloroform, dichlorobenzene, 1,4-dioxane and tetrahydrofuran. In addition, the salts have high potential for the solution processing of an orange-red OLED material and bioimaging application. Traditional fluorescent orange-red materials all depend on transition metal-containing luminous bodies, and the transition metal-containing luminous bodies usually have lower internal quantum yield and a broader spectrum. Because a metal-free luminous body has higher solubility and quantum yield, recent development gradually focuses on the design and synthesis of a metal-free organic material. The organic material, usually having a functional group capable of pushing and pulling electrons to lead to electron transfer, appears as a narrow bandwidth orange-red organic light-emitting diode. Therefore, the 11-arylcinnolino[2,3-f]phenanthridin-9-ium salts can have high potential to serve as a solution-processed orange-red OLED material.
- More specifically, in an embodiment of the invention, 11-arylcinnolino[2,3-f]phenanthridinium salt compounds have the structure of the following formula (A):
- wherein, R is selected from the group consisting of methoxycarbonyl (CO2Me), butoxycarbonyl (CO2Bu), ethoxycarbonyl (CO2Et), (benzyloxy)carbonyl (CO2Bn), (cyclohexyloxy)carbonyl (CO2cyhex), ((tetrahydrofuran-2-yl)methoxy)carbonyl (CO2furfuryl), phenoxycarbonyl (CO7Ph), and dimethylcarbamoyl (CONMe2). Furthermore, the 11-arylcinnolino[2,3-f]phenanthridin-9-ium salts are included in Table 1 below.
-
TABLE 1 The names of 11-arylcinnolino[2,3-f]phenanthridinium No. salt compounds 4aa 15-(Methoxycarbonyl)-11-phenylcinnolino[2,3-f]phenanthridin-9- ium tetrafluoroborate 4ab 15-(Butoxycarbonyl)-11-phenylcinnolino[2,3-f]phenanthridin-9- ium tetrafluoroborate 4ac 15-(Ethoxycarbonyl)-11-phenylcinnolino[2,3-f]phenanthridin-9- ium tetrafluoroborate 4ad 15-((Benzyloxy)carbonyl)-11-phenylcinnolino[2,3-f]phenanthridin- 9-ium tetrafluoroborate 4ae 15-((Cyclohexyloxy)carbonyl)-11- phenylcinnolino[2,3-f]phenanthridin-9-ium tetrafluoroborate 4af 11-Phenyl-15-(((tetrahydrofuran-2- yl)methoxy)carbonyl)cinnolino[2,3-f]phenanthridin-9-ium tetrafluoroborate 4ag 15-(Phenoxycarbonyl)-11-phenylcinnolino[2,3-f]phenanthridin-9- ium tetrafluoroborate 4ah 15-(Dimethylcarbamoyl)-11-phenylcinnolino[2,3-f]phenanthridin- 9-ium tetrafluoroborate - In a different embodiment of the invention, the 11-arylcinnolino[2,3-f]phenanthridinium salt compounds have the structure of the following formula (A):
- wherein, R is selected from the group consisting of acetyl (COMe) and phenyl (Ph).
- Furthermore, the 11-arylcinnolino[2,3-f]phenanthridin-9-ium salts are included in Table 2 below.
-
TABLE 2 The names of 11-arylcinnolino[2,3-f]phenanthridinium No. salt compounds 4ai 15-Acetyl-11-phenylcinnolino[2,3-f]phenanthridin-9-ium tetrafluoroborate 4aj 11,15-Diphenylcinnolino[2,3-f]phenanthridin-9-ium tetrafluoroborate - In a different embodiment, the 11-arylcinnolino[2,3-f]phenanthridinium salt compounds of claim 1 have the structure of the following formula (B):
- wherein, R is selected from the group consisting, of ((tetrahydrofuran-2-yl)methoxy)carbonyl (CO2furfuryl) and dimethylcarbamoyl (CONMe2).
- Furthermore, the 11-arylcinnolino[2,3-f]phenanthridin-9-ium salts are included in Table 3 below.
-
TABLE 3 The names of 11-arylcinnolino[2,3-f]phenanthridinium No. salt compounds 4bf 7,14-Dimethyl-11-phenyl-15-(((tetrahydrofuran-2- yl)methoxy)carbonyl)cinnolino[2,3-f]phenanthridin-9-ium tetrafluoroborate 4bh 15-(Dimethylcarbamoyl)-7,14-dimethyl-11- phenylcinnolino[2,3-f]phenanthridin-9-ium tetrafluoroborate - In a different embodiment of the invention, the 11-arylcinnolino[2,3-f] phenanthridinium salt compounds include 15-(dimethylcarbamoyl)-7,14-dimethyl-11-phenylcinnolino[2,3-f]phenanthridin-9-ium tetrafluoroborate, and have the structure of the following formula (C):
- Furthermore, the 11-arylcinnolino[2,3-f]phenanthridin-9-ium salts are included in Table 4 below.
-
TABLE 4 The names of 11-arylcinnolino[2,3-f]phenanthridinium No. salt compounds 4cf 6,13-Dimethyl-11-phenyl-15-(((tetrahydrofuran-2- yl)methoxy)carbonyl)cinnolino[2,3-f]phenanthridin-9-ium tetrafluoroborate - In a different embodiment of the invention, the 11-arylcinnolino[2,3-f] phenanthridinium salt compounds include 15-(butoxycarbonyl)-3-methyl-11-(m-tolyl)cinnolino[2,3-f]phenanthridin-9-ium tetrafluoroborate, and have the structure of the following formula (D):
- wherein, R includes butoxycarbonyl (CO2Bu), and R2 includes methyl (Me).
- Furthermore, the 11-arylcinnolino[2,3-f]phenanthridin-9-ium salts are included in Table 5 below.
-
TABLE 5 The names of 11-arylcinnolino[2,3-f]phenanthridinium No. salt compounds 4db 15-(Butoxycarbonyl)-3-methyl-11-(m- tolyl)cinnolino[2,3-f]phenanthridin-9-ium tetrafluoroborate - In a different embodiment of the invention, the 11-arylcinnolino[2,3-]phenanthridinium salt compounds include 3-fluoro-11-(3-fluorophenyl)-15-(((tetrahydrofuran-2-yl)methoxy)carbonyl)cinnolino[2,3-f] phenanthridin-9-ium tetrafluoroborate, and have the structure of the following formula (E):
- wherein, R includes ((tetrahydrofuran-2-yl)methoxy)carbonyl (CO2furfuryl), and R2 includes fluorine.
- Furthermore, the 11-arylcinnolino[2,3-f]phenanthridinium salt compounds are included in Table 6 below.
-
TABLE 6 The names of 11-arylcinnolino[2,3-f]phenanthridinium No. salt compounds 4ef 3-fluoro-11-(3-fluorophenyl)-15-(((tetrahydrofuran-2- yl)methoxy)carbonyl)cinnolino[2,3-f]phenanthridin-9-ium tetrafluoroborate - In a different embodiment of the invention, the 11-arylcinnolino[2,3-f]phenanthridinium salt compounds of claim 1 include 15-(butoxycarbonyl)-4-chloro-11-(2-chlorophenyl)cinnolino[2,3-f]phenanthridin-9-ium tetrafluoroborate, and have the structure of the following formula (F):
- Furthermore, the 11-arylcinnolino[2,3-f]phenanthridinium salt compounds are included in Table 7 below.
-
TABLE 7 No. The names of 11-arylcinnolino[2,3-f]phenanthridinium salts 4fb 15-(butoxycarbonyl)-4-chloro-11-(2-chlorophenyl)cinnolino[2,3-f] phenanthridin-9-ium tetrafluoroborate - In a different embodiment of the invention, the 11-arylcinnolino[2,3-f]phenanthridinium salt compounds include 14-(((tetrahydrofuran-2-yl)methoxy)carbonyl)-10-(thiophen-2-yl)thieno[3′,2′:3,4]quinolino[1,2-b]cinnolin-8-ium tetrafluoroborate, and have the structure of the following formula (G):
- Furthermore, the 11-arylcinnolino[2,3-f]phenanthridinium salts are included in Table 8 below.
-
TABLE 8 No. The names of 11-arylcinnolino[2,3-f]phenanthridinium salts 4gf 14-(((tetrahydrofuran-2-yl)methoxy)carbonyl)-10-(thiophen-2- yl)thieno[3′,2′:3,4]quinolino[1,2-b]cinnolin-8-ium tetrafluoroborate - The absorption test and the fluorescence test (1.0×10−5 M, excitation wavelength: 360 nm, in dichloromethane) were performed on the
compounds 2a, 4ab, 4ad, 4ah, 4aj, and 4bf, and the results were shown inFIGS. 1 and 2 respectively. According toFIGS. 1 and 2 , the maximum absorption peak for thecompound 2a appears at 275-400 nm, the maximum absorption peaks for the compounds 4ab, 4ad, 4ah, and 4aj appear at 340 nm, and the maximum absorption peak for the compound 4bf appears at 380 nm. If thecompounds 2a, 4ab, 4ad, 4ah, 4aj, and 4bf were excited at the wavelengths of respective maximum absorption peaks, thecompound 2a was not found to emit fluorescence, while the compounds 4ab, 4ad, 4ah, 4aj, and 4bf can emit orange-red fluorescence at 500-750 nm. These salts exhibit large Stokes shift orange-red fluorescence, which show possible application in IDLED and bioimaging. - Although said descriptions and figures have disclosed preferable embodiments of the invention, it must be understood that possible applications of various additions, many modifications and replacements in preferable embodiments of the invention do not depart from the spirit and scope of the present invention which are as claimed by the appended claims. A person having ordinary skill in the art can realize that the invention can be used in various modifications in structure, arrangements, ratios, material, elements, and components. Therefore, the disclosed embodiments should be regarded as explanations of instead of limitations on the invention. The scope of the invention should be claimed by the appended claims and cover their legal equivalents, and should not be limited to the prior descriptions.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17/161,992 US11970492B2 (en) | 2019-08-30 | 2021-01-29 | 11-arylcinnolino[2,3-f]phenanthridinium salts and method for producing the same |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW108131307A | 2019-08-30 | ||
TW108131307 | 2019-08-30 | ||
TW108131307A TWI753296B (en) | 2019-08-30 | 2019-08-30 | 11-arylcinnolino[2,3-f]phenanthridin-9-ium salts and the manufacturing method thereof |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US17/161,992 Division US11970492B2 (en) | 2019-08-30 | 2021-01-29 | 11-arylcinnolino[2,3-f]phenanthridinium salts and method for producing the same |
Publications (2)
Publication Number | Publication Date |
---|---|
US20210061799A1 true US20210061799A1 (en) | 2021-03-04 |
US10947232B1 US10947232B1 (en) | 2021-03-16 |
Family
ID=74682431
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/664,370 Active US10947232B1 (en) | 2019-08-30 | 2019-10-25 | 11-arylcinnolino[2,3-f]phenanthridinium salts and method for producing the same |
US17/161,992 Active 2041-08-01 US11970492B2 (en) | 2019-08-30 | 2021-01-29 | 11-arylcinnolino[2,3-f]phenanthridinium salts and method for producing the same |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US17/161,992 Active 2041-08-01 US11970492B2 (en) | 2019-08-30 | 2021-01-29 | 11-arylcinnolino[2,3-f]phenanthridinium salts and method for producing the same |
Country Status (2)
Country | Link |
---|---|
US (2) | US10947232B1 (en) |
TW (1) | TWI753296B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114315678A (en) * | 2021-11-24 | 2022-04-12 | 哈尔滨工业大学(深圳) | Novel aryl diperoxy acid and preparation method and application thereof |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI773602B (en) * | 2021-11-29 | 2022-08-01 | 國立陽明交通大學 | Triarylcinnolin-2-ium salts and method of manufacturing the same |
TWI836465B (en) * | 2022-06-08 | 2024-03-21 | 國立陽明交通大學 | Precursor for preparing cinnoline derivative, method for preparing cinnoline derivative and cinnoline derivative |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104817534A (en) * | 2004-03-03 | 2015-08-05 | 塔科达有限责任公司 | Novel hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors |
-
2019
- 2019-08-30 TW TW108131307A patent/TWI753296B/en active
- 2019-10-25 US US16/664,370 patent/US10947232B1/en active Active
-
2021
- 2021-01-29 US US17/161,992 patent/US11970492B2/en active Active
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114315678A (en) * | 2021-11-24 | 2022-04-12 | 哈尔滨工业大学(深圳) | Novel aryl diperoxy acid and preparation method and application thereof |
Also Published As
Publication number | Publication date |
---|---|
US10947232B1 (en) | 2021-03-16 |
TWI753296B (en) | 2022-01-21 |
US20210147420A1 (en) | 2021-05-20 |
US11970492B2 (en) | 2024-04-30 |
TW202108580A (en) | 2021-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11970492B2 (en) | 11-arylcinnolino[2,3-f]phenanthridinium salts and method for producing the same | |
KR20140024377A (en) | Stannyl derivatives of naphthalene diimides and related compositions and methods | |
US11136298B2 (en) | Method for producing fullerene derivative | |
CN113861143A (en) | Thermal activation delayed fluorescence deep blue light material, preparation method thereof and organic electroluminescent device | |
CN111732516B (en) | A kind ofNProcess for preparing (E) -aryl-substituted heterocyclic compounds | |
WO2019114326A1 (en) | Taurine-substituted bodipy fluorescent compound, preparation method therefor and use thereof | |
US20200339560A1 (en) | Process for the preparation of disubstituted diaryloxybenzoheterodiazole compounds | |
KR101460071B1 (en) | Prepartion method for trifluoromethyl substituted heterocycles via visible light photoredox catalysis | |
US20190326523A1 (en) | Tetradentate cyclic-metal palladium complex comprising 4-aryl-3,5-disubstituted pyrazol, preparation and use thereof | |
TWI785816B (en) | 11-arylcinnolino[2,3-f]phenanthridin-9-ium salts and the manufacturing method thereof | |
TWI425077B (en) | Organic luminescent material and organic electroluminescent apparatus | |
US9343687B1 (en) | Imidazo[1,2-A]pyrimidine-containing compounds, method for preparing the same, and their use in electronic devices | |
US9657019B2 (en) | 1,9-diazaphenalene derivative and process for manufacturing the same | |
JP5317084B2 (en) | π-conjugated cyclic compound and process for producing the same | |
ITMI20120417A1 (en) | PROCEDURE FOR THE PREPARATION OF COMPOUNDS TETRACARBOSSINAHTALENDIIMMIDIC DIFFERENCES WITH HETHERARYLIC GROUPS | |
KR20200139098A (en) | A curved aromatic compound and a method of production thereof | |
US20110137024A1 (en) | Method for producing isoindole | |
US10995217B2 (en) | Compounds as potential dye molecules | |
US7884249B2 (en) | Bicyclo compound, method for producing pentacene and a film thereof using the same, and method for producing bicyclo compound | |
US20170170419A1 (en) | Organic fluorescent luminescent material and organic electroluminescent device | |
US20050065338A1 (en) | Total synthesis of galanthamine, analogues and derivatives thereof | |
KR100601039B1 (en) | Novel fluorescent dendrimers and manufacturing method thereof | |
Visniakova et al. | Synthesis of 1, 10-phenanthrolines fused with bicyclo [3.3. 0] octane and bicyclo [3.3. 1] nonane frameworks | |
CN111205188A (en) | Process for producing cycloalkane compound | |
Sekharayya et al. | An improved and scalable process for the synthesis of a key intermediate for Etodolac, a non-steroidal anti-inflammatory drug |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FEPP | Fee payment procedure |
Free format text: ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
AS | Assignment |
Owner name: NATIONAL CHIAO TUNG UNIVERSITY, TAIWAN Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:CHUANG, SHIH-CHING;JAYACHANDRAN, JAYAKUMAR;REEL/FRAME:050843/0496 Effective date: 20191008 |
|
FEPP | Fee payment procedure |
Free format text: ENTITY STATUS SET TO SMALL (ORIGINAL EVENT CODE: SMAL); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YR, SMALL ENTITY (ORIGINAL EVENT CODE: M2551); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY Year of fee payment: 4 |